At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
Thoracic surgery for lung cancerprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Lung Surgery
In Brief
An observational study evaluating Thoracic surgery for lung cancer for Chronic Neuropathic Pain, Postoperative and 4 related conditions. Completed, enrolled 78 participants across 2 sites.
Detailed Summary
To understand pain pathophysiology in terms of risk factors and protective mechanisms ranging from molecular pathways to societal impacts.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Neuropathic Pain, Postoperative, Chronic Pain, Postoperative, Chronic Chemotherapy-induced Neuropathic Pain, Chronic Chemotherapy-induced Pain, Chronic Chemotherapy-induced Peripheral Neuropathy
CountriesDenmark
CollaboratorsDOLORisk Consortium, Aarhus University Hospital
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartJan 2017
Primary CompletionJun 2019
Study CompletionJun 2021
TodayJul 2026
First PostedNov 10, 2016
Enrollment StartJan 2, 2017
Primary CompletionJun 18, 2019
Study CompletionJun 16, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 9.6 years ago
Interventions
Thoracic surgery for lung cancerprocedure
Lung cancer resection performed via Video-assisted thoracoscopic surgery (VATS) and/or thoracotomy, including lobectomy, bilobectomy, pneumonectomy, resection of the tracheobronchial bifurcation, wedge resection, sleeve resection and combinations hereof.